Merck Fosamax 40 mg Distribution Plan Leaves Room For Once-Weekly Agent
Executive Summary
Merck's exclusive distribution program for patients receiving Fosamax 40 mg tablets for Paget's disease will give the company pricing flexibility when a once-weekly 35 mg formulation is approved for prevention of osteoporosis.